Pharmacology and Toxicology Research for Drug Development and Discovery
Envol Biomedical is a leading nonclinical laboratory offering pharmacology and toxicology capabilities focused on nonhuman primates.
Access to the largest population of readily available native and non-native nonhuman primates (old-world and new-world) in the continental U.S.
Dedicated to providing cost-effective studies with extremely fast turn-around time.
Dedicated to the on-time delivery of study samples and study reports (standard and specific study protocols).
AAALAC accredited, USDA and OLAW compliant.
Learn More
Why Choose Envol Biomedical?
Nonhuman primate preclinical research
Largest population available in the continental U.S.
On time delivery of study samples and study reports
AAALAC accredited, USDA and OLAW compliant
Our Capabilities
Envol Biomedical is a leading nonhuman primate research facility that builds on over 20 years of primate capabilities. Our strategy is to 1) create an exceptional team, 2) foster a successful culture, and 3) focus on our clients. Our team applies cutting-edge pharmacology and surgical models to facilitate drug development, primarily in the areas of gene targeting and biologics. We provide pharmacokinetics, pharmacodynamics, and toxicology research to help advance technologies with best-in-class capabilities. The best way to learn about our capabilities is to come visit the laboratory. We look forward to seeing you.We specialize in analyzing drug absorption, distribution, metabolism, and excretion to guide dosing strategies for safe and effective treatments.
Our in-depth understanding of how drugs interact with the body enables precise assessment of their effects, crucial for optimizing therapeutic outcomes.
With a focus on safety, we meticulously evaluate the potential harm of substances, ensuring they meet stringent regulatory standards.
News & Insights
April 11, 2025
What the FDA’s Statement on Animal Testing Really Means: A Call to Action to Continue Improving Efficiency in Drug Development
The “Bombshell” News from the FDA (not really). Let’s Clear the Air… On the heels...April 3, 2025
How Will the Recent Tariffs Affect the Non-Human Primate Research Sector?
The announcement of sweeping new tariffs this week, dubbed “Liberation Day” by the president, has...April 1, 2025
Key Takeaways from SOT 2025: Insights from Envol Biomedical’s CEO, Jacob McDonald
Having attended the Society of Toxicology’s SOT meetings for over 25 years, I’ve seen how...Talk to an Expert About Our Research & Services
For inquiries about our research and services, don't hesitate to get in touch with our experts. Your journey to innovation starts here.
